Trial Profile
Pilot Study of the Safety and Efficacy of Carvedilol in Pulmonary Arterial Hypertension
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Carvedilol (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 06 Jun 2017 Status changed from recruiting to completed.
- 01 Jul 2014 New trial record
- 15 Jun 2014 Primary endpoint has been met (Absolute change in right ventricular ejection fraction) according to results published in the American Journal of Respiratory and Critical Care Medicine.